Sarme, Mariano C.

HRN: 21-41-23  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/31/2022
06/06/2022
IV
2.25gram
Q6hrs
Sepsis Secondary To Urosepsis

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines